Tyrosine-Free Amino Acid Mixture Attenuates Amphetamine-Induced Displacement of [11C]Raclopride in Striatum in Vivo: A Rat PET Study

Synapse

Volumn 51, Issue 2, 2004, Pages 151-157

  Le Masurier, Marisa ^a   Houston, Gavin ^b   Cowen, Philip ^c   Grasby, Paul ^b   Sharp, Trevor ^a   Hume, Susan ^b  

^a OX1 3QT   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Dopamine; PET; Tyrosine

Indexed keywords

AMINO ACID; AMPHETAMINE DERIVATIVE; DOPAMINE; PSYCHOSTIMULANT AGENT; RACLOPRIDE C 11; SODIUM CHLORIDE; TRACER; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT;

AMINO ACIDS; AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; BRAIN MAPPING; CARBON ISOTOPES; CARBON RADIOISOTOPES; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBELLUM; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; MALE; MODELS, ANIMAL; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; TOMOGRAPHY, EMISSION-COMPUTED; TYROSINE;

EID: 0347511690     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10285     Document Type: Article

References (25)

1. Boado R, Li J, Nagaya M, Zhang C, Pardridge W. 1999. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci USA 96:12079-12084.
2. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D. 1997. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94:2569-2574.
3. Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, Malhotra AK, Pickar D. 1998. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse 29:142-147.
4. 11C-raclopride and positron emission tomography. J Neurosci 12:3773-3780.
5. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13:350-356.
6. Dewey SL, Smith GS, Logan J, Alexoff D, Ding YS, King P, Pappas N, Brodie JD, Ashby CR Jr. 1995. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neurosci 15:821-829.
7. 11C-raclopride in living human brain-a search for extrastriatal central D2-dopamine receptors by PET. Psychopharmacology (Berl) 94:471-478.
8. 11C]raclopride binding in the cat striatum. Neuroimage 7.
9. Harmer CJ, McTavish SF, Clark L, Goodwin GM, Cowen PJ. 2001. Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology (Berl) 154:105-111.
10. 11C] raclopride in anaesthetised rodents. NeuroImage 16:S11.
11. Hume SP, Myers R. 2002. Dedicated small animal scanners: a new tool for drug development? Curr Pharm Des 8:1497-1511.
12. Hume SP, Myers R, Bloomfield PM, Opacka-Juffry J, Cremer JE, Ahier RG, Luthra SK, Brooks DJ, Lammertsma AA. 1992. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12:47-54.
13. 11C]raclopride binding in rat striatum, quantified using PET. Synapse 21:45-53.
14. Hume SP, Lammertsma AA, Myers R, Rajeswaran S, Bloomfield PM, Ashworth S, Fricker RA, Torres EM, Watson I, Jones T. 1996. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. J Neurosci Methods 67:103-112.
15. Hume SP, Gunn RN, Jones T. 1998. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur J Nucl Med 25:173-176.
16. 1A receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine. Synapse 41:150-159.
17. Jeavons AP, Chandler RA, Dettmar CAR. 1999. A 3D HIDAC-PET camera with sub-millimetre resolution for imaging small animals. IEEE Trans Nucl Sci 46:468-473.
18. Laruelle M. 2000. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423-451.
19. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB. 1996. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93:9235-9240.
20. Le Masurier M, Cowen P, Sharp T. 2003. Fos immunocytochemical studies on the neuroanatomical sites of action of acute tyrosine depletion in the rat brain. Psychopharmacology (in press).
21. McTavish SFB, Cowen PJ, Sharp T. 1999. Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology 141:182-188.
22. McTavish SFB, McPherson MH, Harmer CJ, Clark L, Sharp T, Goodwin GM, Cowen PJ. 2001a. Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 179:356-360.
23. McTavish SFB, Raumann B, Cowen PJ, Sharp T. 2001b. Tyrosine depletion attenuates the behavioral stimulant effects of amphetamine and cocaine in rats. Eur J Pharmacol 424:115-119.
24. Paxinos G, Watson C. 1996. The rat brain in stereotaxic coordinates. Compact Third Edition. London: Academic Press.
25. Robb RA. 2001. The biomedical imaging resource at Mayo Clinic. Guest Editorial. IEEE Trans Med Imag 20:217-226.